نتایج جستجو برای: urate oxidae

تعداد نتایج: 4122  

2016
Luyu Yang Zheng Dong Jingru zhou Yanyun Ma Weilin Pu Dongbao Zhao Hongjun He Hengdong Ji Yajun Yang Xiaofeng Wang Xia Xu Yafei Pang Hejian Zou Li Jin Chengde Yang Jiucun Wang

Elevated serum urate, which is regulated at multiple levels including genetic variants, is a risk factor for gout and other metabolic diseases. This study aimed to investigate the association between UCP2 variants and serum urate as well as hyperuricemia in a Chinese population. In total, 4332 individuals were genotyped for two common UCP2 variants, -866G/A and Ala55Val. These loci were not ass...

2017
Tristan Pascart Agathe Grandjean Laurène Norberciak Vincent Ducoulombier Marguerite Motte Hélène Luraschi Marie Vandecandelaere Catherine Godart Eric Houvenagel Nasser Namane Jean-François Budzik

BACKGROUND Ultrasonography (US) and dual-energy computed tomography (DECT) can assess urate burden in gout. The objective of this study was to compare the quantification of urate deposition provided by US to the one provided by DECT. METHODS Patients with a diagnosis of gout were prospectively recruited to undergo quantification of urate deposition using US and DECT. US examination for tophi ...

2015
Nicola Doniselli Enrico Monzeglio Alessandro Dal Palù Angelo Merli Riccardo Percudani

In living organisms, the conversion of urate into allantoin requires three consecutive enzymes. The pathway was lost in hominid, predisposing humans to hyperuricemia and gout. Among other species, the genomic distribution of the two last enzymes of the pathway is wider than that of urate oxidase (Uox), suggesting the presence of unknown genes encoding Uox. Here we combine gene network analysis ...

2017
Richard O Day Lauren J Frensham Amy D Nguyen Melissa T Baysari Eindra Aung Annie Y S Lau Nicholas Zwar Jennifer Reath Tracey Laba Ling Li Andrew McLachlan William B Runciman Rachelle Buchbinder Robyn Clay-Williams Enrico Coiera Jeffrey Braithwaite H Patrick McNeil David J Hunter Kevin D Pile Ian Portek Kenneth Mapson WIlliams Johanna I Westbrook

INTRODUCTION Gout is increasing despite effective therapies to lower serum urate concentrations to 0.36 mmol/L or less, which, if sustained, significantly reduces acute attacks of gout. Adherence to urate-lowering therapy (ULT) is poor, with rates of less than 50% 1 year after initiation of ULT. Attempts to increase adherence in gout patients have been disappointing. We aim to evaluate the effe...

2011
Victoria M Kelly Eswar Krishnan

of disease process & therapeutic targets Hyperuricemia, as defined by a serum urate ≥6.8 mg/dl, is necessary but not sufficient to produce the clinical manifestations of gouty arthritis (gout) [1]. Hyperuricemia develops whenever there is a relative imbalance of production and excretion of urate. There are several other risk factors associated with the development of gout, mostly related to the...

Journal: :Journal of clinical pharmacy and therapeutics 2016
T Hosoya Y Ogawa H Hashimoto T Ohashi R Sakamoto

WHAT IS KNOWN AND OBJECTIVE There are no clinical reports that have compared topiroxostat, a selective xanthine oxidase inhibitor, with allopurinol in serum urate-lowering efficacy. The aim of this study was to compare the efficacy and safety of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout. METHODS A phase 3, multicentre, randomized, double-blind, doubl...

Journal: :The lancet. Diabetes & endocrinology 2016
Jon White Reecha Sofat Gibran Hemani Tina Shah Jorgen Engmann Caroline Dale Sonia Shah Felix A Kruger Claudia Giambartolomei Daniel I Swerdlow Tom Palmer Stela McLachlan Claudia Langenberg Delilah Zabaneh Ruth Lovering Alana Cavadino Barbara Jefferis Chris Finan Andrew Wong Antoinette Amuzu Ken Ong Tom R Gaunt Helen Warren Teri-Louise Davies Fotios Drenos Jackie Cooper Shah Ebrahim Debbie A Lawlor Philippa J Talmud Steve E Humphries Christine Power Elina Hypponen Marcus Richards Rebecca Hardy Diana Kuh Nicholas Wareham Yoav Ben-Shlomo Ian N Day Peter Whincup Richard Morris Mark W J Strachan Jacqueline Price Meena Kumari Mika Kivimaki Vincent Plagnol John C Whittaker George Davey Smith Frank Dudbridge Juan P Casas Michael V Holmes Aroon D Hingorani

BACKGROUND Increased circulating plasma urate concentration is associated with an increased risk of coronary heart disease, but the extent of any causative effect of urate on risk of coronary heart disease is still unclear. In this study, we aimed to clarify any causal role of urate on coronary heart disease risk using Mendelian randomisation analysis. METHODS We first did a fixed-effects met...

Journal: :Proceedings of the National Academy of Sciences 1994

Journal: :The Journal of clinical investigation 2001
M S Lipkowitz E Leal-Pinto J Z Rappoport V Najfeld R G Abramson

Elevated serum levels of uric acid have been associated with an increased risk for gout, hypertension, cardiovascular disease, and renal failure. The molecular mechanisms for the diminished excretion of urate in these disorders, however, remain poorly understood. Human galectin 9, which is highly homologous to the rat urate transporter rUAT, has been reported to be a secreted or cytosolic prote...

Journal: :Journal of the American Society of Nephrology : JASN 2004
Kimiyoshi Ichida Makoto Hosoyamada Ichiro Hisatome Atsushi Enomoto Miho Hikita Hitoshi Endou Tatsuo Hosoya

Renal hypouricemia is an inherited and heterogeneous disorder characterized by increased urate clearance (CUA). The authors recently established that urate was reabsorbed via URAT1 on the tubular apical membrane and that mutations in SLC22A12 encoding URAT1 cause renal hypouricemia. This study was undertaken to elucidate and correlate clinical and genetic features of renal hypouricemia. The SLC...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید